High-throughput combinatorial screening of antiplatelet drugs for personalized medicine

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Pharmacology

Background:

• Cardiovascular disease (CVD) is a leading global cause of death, with platelet activation central to thrombotic events.
• Current antiplatelet therapies face challenges including bleeding risks, adverse effects, drug resistance, and significant inter-individual response variability.
• The need for personalized antiplatelet drug regimens necessitates efficient screening methods for optimal drug selection and combination therapy.

Purpose of the Study:

• To develop and validate a high-throughput platform, the C-chip, for screening antiplatelet drug combinations.
• To assess the C-chip's capability in identifying optimal combinations of clinically relevant antiplatelet drugs.
• To investigate inter-individual variability in patient responses to antiplatelet drug combinations.

Main Methods:

• Development of the C-chip, a platform utilizing miniaturized, picoliter-volume, color-coded droplets for parallel screening.
• On-chip screening of combinations of Aspirin, Tirofiban, and Ticagrelor.
• Application of the C-chip to screen antiplatelet drug combinations in samples from healthy volunteers.

Main Results:

• The C-chip successfully miniaturizes screening reactions, generating thousands of data points per experiment.
• The platform effectively identified optimal combinations of Aspirin, Tirofiban, and Ticagrelor.
• Screening of five healthy volunteers using the C-chip revealed substantial inter-individual variability in antiplatelet drug responses.

Conclusions:

• The C-chip offers a high-throughput solution for screening antiplatelet agents, overcoming limitations of traditional assays.
• This platform facilitates the identification of personalized antiplatelet drug combinations tailored to individual patient needs.
• The findings highlight the critical importance of personalized medicine approaches in managing cardiovascular disease.